Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop pre-eclampsia later in pregnancy: Implications for screening

Prenatal Diagnosis

Volumn 31, Issue 2, 2011, Pages 181-185

  Farina, Antonio ^a   Zucchini, Cinzia ^a   De Sanctis, Paola ^a   Morano, Danila ^a   Sekizawa, Akihiko ^b   Purwosunu, Yuditiya ^b,c   Okai, Takashi ^b   Rizzo, Nicola ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

Chorionic villous samples; MRNA; Real time PCR; Screening for pre eclampsia

Indexed keywords

ANGIOPOIETIN 2; CATHEPSIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; HLA C ANTIGEN; HLA G ANTIGEN; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; NEUROKININ B;

ADULT; ARTICLE; CASE CONTROL STUDY; CHORION VILLUS SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; PREECLAMPSIA; PRIORITY JOURNAL;

ADULT; CASE-CONTROL STUDIES; CHORIONIC VILLI; CHORIONIC VILLI SAMPLING; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MASS SCREENING; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST;

EID: 79251507017     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2675     Document Type: Article

References (43)

1. Adusumalli J, Han CS, Beckham S, Bartholomew ML, Williams J III. 2007. Chorionic villus sampling and risk for hypertensive disorders of pregnancy. Am J Obstet Gynecol 196: 591.e1-e7. discussion 591.e7.
2. Apps R, Gardner L, Moffett A. 2008. A critical look at HLA-G. Trends Immunol 29: 313-321.
3. Baggiolini M, Walz A, Kunkel SL. 1989. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84: 1045-1049.
4. Belperio JA, Keane MP, Arenberg DA, et al. 2000. CXC chemokines in angiogenesis. J Leukoc Biol 68: 1-8.
5. Bernardini G, Ribatti D, Spinetti G, et al. 2003. Analysis of the role of chemokines in angiogenesis. J Immunol Methods 273: 83-101.
6. Brownbill P, Bell NJ, Woods RJ, Lowry PJ, Page NM, Sibley CP. 2003. Neurokinin B is a paracrine vasodilator in the human fetal placental circulation. J Clin Endocrinol Metab 88: 2164-2170.
7. Campbell S, Rowe J, Jackson CJ, Gallery ED. 2004. Interaction of cocultured decidual endothelial cells and cytotrophoblasts in preeclampsia. Biol Reprod 71: 244-252.
8. D'Anna R, Baviera G, Corrado F, et al. 2004. Neurokinin B and nitric oxide plasma levels in pre-eclampsia and isolated intrauterine growth restriction. BJOG 111: 1046-1050.
9. De Groot CJ, Bloemenkamp KW, Duvekot EJ, et al. 1999. Pre-eclampsia and genetic risk factors for thrombosis: a case-control study. Am J Obstet Gynecol 181: 975-980.
10. Denison FC, Kelly RW, Calder AA. 1997. Differential secretion of chemokines from peripheral blood in pregnant compared with non-pregnant women. J Reprod Immunol 34: 225-240.
11. Goldman-Wohl DS, Ariel I, Greenfield C, Hanoch J, Yagel S. 2000a. HLA-G expression in extravillous trophoblasts is an intrinsic property of cell differentiation: a lesson learned from ectopic pregnancies. Mol Hum Reprod 6: 535-540.
12. Goldman-Wohl DS, Ariel I, Greenfield C, et al. 2000b. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol Hum Reprod 6: 88-95.
13. Goldsby RA, Kindt TJ, Osborne BA, Kuby J. 2003. Leukocyte migration and inflammation. Immunology, W. H. Freeman and Company: New York; 338-360.
14. Gotsch F, Romero R, Friel L, et al. 2007. CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia? J Matern Fetal Neonatal Med 20: 777-792.
15. Hackmon R, Koifman A, Hyodo H, Glickman H, Sheiner E, Geraghty DE. 2007. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. Am J Obstet Gynecol 97: 255.e1-5.
16. Hanna J, Goldman-Wohl D, Hamani Y, et al. 2006. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 12: 1065-1074.
17. Hara N, Fujii T, Yamashita T, Kozuma S, Okai T, Taketani Y. 1996. Altered expression of human leukocyte antigen G (HLA-G)on extravillous trophoblasts in preeclampsia: immunohistological demonstration with anti-HLA-G specific antibody "87G'" and anticytokeratin antibody "CAM5 2". Am J Reprod Immunol 36: 349-358.
18. Hiby SE, Walker JJ, O'Shaughnessy KM, et al. 2004. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia andreproductive success. J Exp Med 200: 957-965.
19. Kauma S, Takacs P, Scordalakes C, Walsh S, Green K, Peng T. 2002. Increased endothelial monocyte chemoattractant protein-1 and interleukin-8 in preeclampsia. Obstet Gynecol 100: 706-714.
20. Kelly BA, Bond BC, Poston L. 2003. Gestational profile of matrix metalloproteinases in rat uterine artery. Mol Hum Reprod 9: 351-358.
21. Kolben M, Lopens A, Blaser J, et al. 1996. Proteases and their inhibitors are indicative in gestational disease. Eur J Obstet Gynecol Reprod Biol 68: 59-65.
22. Laliberte C, DiMarzo L, Morrish DW, Kaufman S. 2004. Neurokinin B causes concentration-dependent relaxation of isolated human placental resistance vessels. Regul Pept 117: 123-126.
23. Le Bouteiller P, Tabiasco J. 2006. Killers become builders during pregnancy. Nat Med 12: 991-992.
24. Lim KH, Zhou Y, Janatpour M, et al. 1997. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am J Pathol 151: 1809-1918.
25. MacKay AP, Berg CJ, Atrash HK. 2001. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 97: 533-538.
26. Montagnana M, Lippi G, Albiero A, et al. 2009. Evaluation of metalloproteinases 2 and 9 and their inhibitors in physiologic and pre-eclamptic pregnancy. J Clin Lab Anal 23: 88-92.
27. Neville LF, Mathiak G, Bagasra O. 1997. The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. Cytokine Growth Factor Rev 8: 207-219.
28. O'Brien M, Dausset M, Carosella E, Moreau P. 2000. Analysis of the role of HLA-G in preeclampsia. Human Immunol 61: 1126-1131.
29. Page NM. 2004. Hemokinins and endokinins. Cell Mol Life Sci 61: 1652-1663.
30. Page NM. 2005. New challenges in the study of the mammalian tachykinins. Peptides 26: 1356-1368.
31. Page NM, Woods RJ, Gardiner SM, et al. 2000. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature 405: 797-800.
32. Page NM, Woods RJ, Lowry PJ. 2001. A regulatory role for neurokinin B in placental physiology and pre-eclampsia. Regul Pept 98: 97-104.
33. Parham P. 2004. NK cells and trophoblasts: partners in pregnancy. J Exp Med 200: 951-955.
34. Poon LC, Nekrasova E, Anastassopoulos P, Livanos P, Nicolaides KH. 2009. First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome. Prenat Diagn 29: 553-559.
35. Purwosunu Y, Sekizawa A, Koide K, et al. 2007. Cell-free mRNA concentrations of plasminogen activator inhibitor-1 and tissue-type plasminogen activator are increased in the plasma of pregnant women with preeclampsia. Clin Chem 53: 399-404.
36. Rosenkilde MM, Schwartz TW. 2004. The chemokine system-a major regulator of angiogenesis in health and disease. APMIS 112: 481-495.
37. Sharma A, Satyam A, Sharma JB. 2007. Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol 58: 21-30.
38. Sibai BM, Barton JR. 2007. Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications. Am J Obstet Gynecol 196: 514.e1-e9.
39. Strieter RM, Burdick MD, Gomperts BN, et al. 2005. CXC chemokines in angiogenesis. Cytokine Growth Factor Rev 16: 593-609.
40. Wang Z, Lu S, Liu C, et al. 2009. Expressional and epigenetic alterations of placental matrix metalloproteinase 9 in preeclampsia. Gynecol Endocrinol 31: 1-7.
41. Walker JJ. 2000. Pre-eclampsia. Lancet 356: 1260-1265.
42. Yie SM, Li LH, Li YM, Librach C. 2004. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. Am J Obstet Gynecol 191: 525-529.
43. Yie SM, Taylor RN, Librach C. 2005. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy. Am J Obstet Gynecol 193: 204-208.